Sangamo Therapeutics
SGMO
$1.70
Share price
-2.30%
Change (1 day)
-70.33%
Change (1 year)
Categories
Sangamo Therapeutics (SGMO) Fails to deliver data
Key failure to deliver metrics for Sangamo Therapeutics :
- Last SEC data release: 2023-02-28
- Last 15 days FTD volume: $2.65 M
- Last 3 months FTD volume: $3.59 M
- Last year FTD volume: $9.27 M
Failures to deliver for Sangamo Therapeutics (SGMO) - 3 month history
Number of shares, 3 month chartBiweekly Failures to deliver volume for Sangamo Therapeutics (SGMO) - since 2013
Volume in USD (price x number of shares), data since 2013Sangamo Therapeutics (SGMO) Failure to deliver volume, Year over Year
| Year | Volume (Price x Shares) | Change |
|---|---|---|
| 2023 | $3.38 M | -45.55% |
| 2022 | $6.21 M | -48.43% |
| 2021 | $12.05 M | 13.65% |
| 2020 | $10.6 M | -37.79% |
| 2019 | $17.04 M | -14.89% |
| 2018 | $20.03 M | 137.05% |
| 2017 | $8.45 M | 53.48% |
| 2016 | $5.5 M | -84.06% |
| 2015 | $34.54 M | 110.75% |
| 2014 | $16.39 M | 339.07% |
| 2013 | $3.73 M |
FTD volume in the last 3 months for similar companies or competitors
| Company | FTD volume (3months) | FTD volume (1 year) | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | $66.53 M | $0.31 B | 🇺🇸 USA |
 Amgen AMGN | $81.07 M | $0.51 B | 🇺🇸 USA |
 Biogen BIIB | $8.79 M | $65.55 M | 🇺🇸 USA |
 Dow DOW | $18.35 M | $0.11 B | 🇺🇸 USA |
 Gilead Sciences GILD | $33.96 M | $0.28 B | 🇺🇸 USA |
 Merck MRK | $0.24 B | $0.58 B | 🇺🇸 USA |
 Alnylam Pharmaceuticals
ALNY | $33.67 M | $0.16 B | 🇺🇸 USA |
 BioMarin Pharmaceutical BMRN | $4.77 M | $26.2 M | 🇺🇸 USA |